ipharmaservicesSep 1GSK's Nucala Receives Approval in Japan for Treating Adults with Chronic Rhinosinusitis with Nasal Polyps | iPharmaCenter
ipharmaservicesJun 24GSK’s Omjjara (Momelotinib) Receives Approval in Japan for Myelofibrosis Treatment | 2024 | iPharmaCenter
ipharmaservicesDec 24, 2022Drug approvals in Japan | PMDA | MHLW Approvals | 2022 | News | Media | Japan | iPharmaCenter
ipharmaservicesJan 12, 2021Novartis and BeiGene collaboration strengthens the Swiss drugmaker's oncology portfolio
ipharmaservicesSep 26, 2020Gilead received the approval of Jyseleca from the European and Japan regulatory authorities for RA
ipharmaservicesAug 22, 2020AZ received one more approval in Japan, received approval of Imfinzi for SCLC
